CONSTA in Polynesian Subjects

Not Applicable

Recruiting

• Conditions: Schizophrenia; Mental Health - Schizophrenia

• Registration Number: ACTRN12605000384651
• Lead Sponsor: Janssen-Cilag

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Primary disgnosis of schizophreniaUnder care of an ethnic specific service.

Exclusion Criteria

Unable to give consent.Risperidone prescription contra-indicated.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptomatic and functional improvement over a one year period[]

Secondary Outcome Measures

Name	Time	Method
Stability of improvement [On two year follow up.];Medication acceptability and side effects[]